Overview

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

Status:
Recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
This randomized clinical trial is designed to evaluate the effect of selected antioxidant vitamins and minerals supplement: 1. β- Carotene (3 mg) 2. Vit C (100 mg) 3. Vit E (Alpha-Tocopherol Acetate): 60 IU 4. Vit D (500 IU) 5. Zinc (4 mg, elemental) 6. Copper (0.5 mg, elemental) 7. Selenium 100 µg (as Sodium Selenite) in patients with mild Thyroid eye disease according to EUGOGO classification. To be given twice a day.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Iran University of Medical Sciences
Treatments:
Antioxidants
Selenium